(0.24%) 5 143.75 points
(0.16%) 38 502 points
(0.34%) 17 906 points
(0.04%) $83.88
(0.57%) $1.934
(0.25%) $2 353.00
(0.42%) $27.65
(2.09%) $941.35
(-0.18%) $0.933
(-0.33%) $10.99
(-0.31%) $0.798
(1.56%) $93.31
Live Chart Being Loaded With Signals
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China...
Stats | |
---|---|
आज की मात्रा | 117 000 |
औसत मात्रा | 243 688 |
बाजार मूल्य | 2.74B |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.360 ( 2023-06-16 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.27 |
ATR14 | HKD0.0110 (0.30%) |
Golden Throat Holdings सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Golden Throat Holdings वित्तीय
Annual | 2023 |
राजस्व: | HKD961.38M |
सकल लाभ: | HKD697.72M (72.57 %) |
EPS: | HKD0.340 |
FY | 2023 |
राजस्व: | HKD961.38M |
सकल लाभ: | HKD697.72M (72.57 %) |
EPS: | HKD0.340 |
FY | 2022 |
राजस्व: | HKD992.01M |
सकल लाभ: | HKD720.92M (72.67 %) |
EPS: | HKD0.380 |
FY | 2021 |
राजस्व: | HKD820.54M |
सकल लाभ: | HKD577.74M (70.41 %) |
EPS: | HKD0.250 |
Financial Reports:
No articles found.
Golden Throat Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.360 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0600 | 2016-05-26 |
Last Dividend | HKD0.360 | 2023-06-16 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 10 | -- |
Total Paid Out | HKD1.140 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.61 | -- |
Div. Sustainability Score | 8.35 | |
Div.Growth Potential Score | 5.03 | |
Div. Directional Score | 6.69 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3998.HK | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
1811.HK | Ex Dividend Junior | 2023-06-06 | Sporadic | 0 | 0.00% | |
0839.HK | Ex Dividend Knight | 2023-06-09 | Semi-Annually | 0 | 0.00% | |
0004.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
2388.HK | Ex Dividend Knight | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
1378.HK | Ex Dividend Knight | 2023-11-16 | Annually | 0 | 0.00% | |
0440.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
6820.HK | No Dividend Player | 2023-05-18 | Annually | 0 | 0.00% | |
1929.HK | Ex Dividend Knight | 2023-07-12 | Semi-Annually | 0 | 0.00% | |
0956.HK | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.260 | 1.500 | 4.80 | 7.19 | [0 - 0.5] |
returnOnAssetsTTM | 0.109 | 1.200 | 6.37 | 7.65 | [0 - 0.3] |
returnOnEquityTTM | 0.168 | 1.500 | 9.25 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.972 | -1.000 | 0.279 | -0.279 | [0 - 1] |
currentRatioTTM | 2.57 | 0.800 | 2.14 | 1.715 | [1 - 3] |
quickRatioTTM | 2.11 | 0.800 | 2.29 | 1.833 | [0.8 - 2.5] |
cashRatioTTM | 1.460 | 1.500 | 3.00 | 4.50 | [0.2 - 2] |
debtRatioTTM | 0.179 | -1.500 | 7.01 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.348 | 2.00 | 9.88 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.337 | 2.00 | 9.83 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.266 | -1.500 | 8.94 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.726 | 1.000 | 1.238 | 1.238 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.350 | 1.000 | 4.99 | 4.99 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.624 | 1.000 | 7.65 | 7.65 | [0.2 - 2] |
assetTurnoverTTM | 0.418 | 0.800 | -0.546 | -0.436 | [0.5 - 2] |
Total Score | 8.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.17 | 1.000 | 9.07 | 0 | [1 - 100] |
returnOnEquityTTM | 0.168 | 2.50 | 9.51 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.337 | 2.00 | 9.89 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 10.46 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.348 | 2.00 | 9.88 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.972 | 1.500 | 0.279 | -0.279 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.268 | 1.000 | 5.81 | 0 | [0.1 - 0.5] |
Total Score | 5.03 |
Golden Throat Holdings
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं